Occurrence and significance of Clostridium difficile in faecal specimens of hospitalized children

Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
W KarschR Schulz

Abstract

Stool specimens from 766 hospitalized children, 418 with diarrhoea and 348 controls, were investigated for C. difficile. In both groups the rate of isolation was highest (about 30%) during the first year of life, dropping to nearly 5% in older children. There was no significant difference in the frequency of C. difficile in children with diarrhoea and the controls nor was there a significant influence of previous antibiotic therapy on the rate of isolation. 111/135 strains (82.2%) produced toxin B and 58/135 strains (43%) produced toxin A measured by Y-1- cell culture (toxin B) and rabbit ileal loop test (toxin A). We did not find any significant difference in the toxin production between strains isolated from diarrhoeal children and from the controls. A total of 285 stool specimens was investigated for toxin B production in vivo. There was no significant difference of toxin B in the stool specimens of both groups.

References

May 20, 1978·Lancet·H E LarsonS P Borriello
Apr 15, 1978·Lancet·W L GeorgeS M Finegold
Feb 1, 1979·Journal of Clinical Microbiology·W L GeorgeS M Finegold
Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
Mar 18, 1978·British Medical Journal·R H GeorgeD W Burdon
Oct 1, 1987·European Journal of Clinical Microbiology·M Camorlinga-PonceJ F Torres
Jun 1, 1986·The Journal of Infectious Diseases·R A Bowman, T V Riley
Aug 1, 1986·European Journal of Clinical Microbiology·S J Wood-HelieS Shadomy
Feb 1, 1986·European Journal of Pediatrics·V MeridaJ Vandepitte
Mar 1, 1985·Journal of Clinical Microbiology·M DelmeeG Wauters
Feb 1, 1980·The Journal of Infectious Diseases·S T Donta, S J Shaffer
Sep 1, 1983·The Journal of Infectious Diseases·J M LibbyT D Wilkins
Jan 1, 1984·Acta paediatrica Scandinavica·T VesikariP Grönroos
Jan 30, 1982·British Medical Journal·B K MandalM Ellis
Jun 1, 1983·Journal of Clinical Microbiology·T L SellF R Fekety
Jan 1, 1981·Scandinavian Journal of Infectious Diseases·E HolstP A Mårdh
Dec 1, 1981·Infection and Immunity·N S TaylorJ G Bartlett
Jun 1, 1980·Infection and Immunity·M EhrichT D Wilkins
Oct 1, 1953·The Journal of Pathology and Bacteriology·S N DE, D N CHATTERJE

❮ Previous
Next ❯

Citations

Jun 21, 2005·Diagnostic Microbiology and Infectious Disease·Patrick TangSusan E Richardson
Sep 21, 2000·Journal of Pediatric Gastroenterology and Nutrition·L V McFarlandS Guandalini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
F BondH Humphreys
The Journal of Infectious Diseases
H E LarsonI D Hill
The New England Journal of Medicine
F C Fang, N E Madinger
© 2022 Meta ULC. All rights reserved